Cytokinetics CYTK PA — Operating Lease Weighted Average Discount Rate Percent
Discontinued — last reported Q3 '23
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Cytokinetics’s 10-Q, filed November 3, 2023, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's pa — operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytokinetics's PA — operating lease weighted average discount rate percent?
- Cytokinetics (CYTK) reported PA — operating lease weighted average discount rate percent of 8.3% in Q3 2023.
- How has Cytokinetics's PA — operating lease weighted average discount rate percent changed year-over-year?
- Cytokinetics's PA — operating lease weighted average discount rate percent decreased by 0.0% year-over-year, from 8.3% to 8.3%.
- What does PA — operating lease weighted average discount rate percent mean?
- The average interest rate applied to the company's total operating lease portfolio.
- How do you interpret PA — operating lease weighted average discount rate percent?
- A lower percentage indicates more efficient financing of lease obligations relative to market benchmarks.
- How does PA — operating lease weighted average discount rate percent compare across companies?
- Standard disclosure under lease accounting standards for portfolio-level financing costs.